Arceo, Erwin D.

HRN: 22-51-95  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2023
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
02/03/2023
02/10/2023
TOPICAL
1g
Bid
Eye Abrasion
Waiting Final Action 
02/03/2023
MUPIROCIN 2%, 15G (TUBE)
02/03/2023
02/10/2023
TOPICAL
1g
Bid
Facial Abrasion
Waiting Final Action 
02/03/2023
CEFUROXIME 1.5GM (VIAL)
02/03/2023
02/10/2023
IV
1.5g
Q8h
Post OR
Waiting Final Action 
02/03/2023
CEFUROXIME 750MG (VIAL)
02/03/2023
02/09/2023
IV
750mg
Q6
S/p ORIF
Waiting Final Action 
02/05/2023
CEFUROXIME 500MG (TAB)
02/05/2023
02/12/2023
ORAL
500mg
TID
S/p Open Reduction Of Zygomaticmaxillary Fracture
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: